RAWCLIFFE ADRIAN (Chief Financial Officer) sold 40.8% of their position (30.60K shares) of ADAPTIMMUNE THERAPEUTICS PLC on the open market
Open‑market sale worth $17.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/17/2025ACC: 0001104659-25-004605
Officer· Chief Financial Officer
Since Jan 2019
-30.60K
Net shares
Net seller
$17.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30.60K disposed
Non-Derivative Transactions1
American Depositary Shares representing Ordinary Shares
Direct
Shares
−30.60K
Price / share
$0.58
Trade value
$17.77K
% of position
40.8%
1/17/2025
74.93K→44.33K
Total
Net shares
−30.60K
Net value
-$17.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 1/17/2025 | S · Sale | −30.60K | $0.58 | $17.77K | 40.8% | 74.93K | 44.33K |
| Total | −30.60K | -$17.77K | ||||||
Derivative Transactions0
No derivative transactions reported